Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
Many vaccine candidates with promising results in preclinical testing fail in human trials. New complex human tissue models have the potential to improve the predictability of vaccine safety and efficacy in human clinical trials.
Saved in:
Main Authors: | David Komla Kessie, Thomas Rudel |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3e9a2bb220b045d4ae6e75a8ae2950f2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep sequencing and automated histochemistry of human tissue slice cultures improve their usability as preclinical model for cancer research
by: Susann Haehnel, et al.
Published: (2019) -
Preclinical Advances of Therapies for Laminopathies
by: Louise Benarroch, et al.
Published: (2021) -
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans
by: Kelly E. Seaton, et al.
Published: (2021) -
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
by: Nan Li, et al.
Published: (2021) -
Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
by: M. Tarek Elghetany, et al.
Published: (2021)